TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to assess the treatment effect of intravenous TAK-954 in improving the average daily protein adequacy received through enteral nutrition in critically-ill participants developing EFI.
Epistemonikos ID: d394cf74ba15ca42ac8f1d73de0a243cb4f8f91b
First added on: May 21, 2024